nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—amyotrophic lateral sclerosis	0.667	1	CbGaD
Aminosalicylic Acid—Methaemoglobinaemia—Riluzole—amyotrophic lateral sclerosis	0.0181	0.166	CcSEcCtD
Aminosalicylic Acid—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.0123	0.113	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0395	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0375	CcSEcCtD
Aminosalicylic Acid—Purpura—Riluzole—amyotrophic lateral sclerosis	0.004	0.0367	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00385	0.0353	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00335	0.0308	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0276	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00291	0.0267	CcSEcCtD
Aminosalicylic Acid—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0265	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0254	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0244	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00263	0.0241	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00261	0.024	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00232	0.0213	CcSEcCtD
Aminosalicylic Acid—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00229	0.021	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00227	0.0208	CcSEcCtD
Aminosalicylic Acid—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0197	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0191	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00196	0.018	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00186	0.017	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00185	0.017	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0169	CcSEcCtD
Aminosalicylic Acid—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0166	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0151	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00164	0.015	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0142	CcSEcCtD
Aminosalicylic Acid—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0138	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0137	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0137	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0128	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0119	CcSEcCtD
Aminosalicylic Acid—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0115	CcSEcCtD
Aminosalicylic Acid—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0012	0.011	CcSEcCtD
Aminosalicylic Acid—Rash—Riluzole—amyotrophic lateral sclerosis	0.00119	0.011	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0109	CcSEcCtD
Aminosalicylic Acid—Headache—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0109	CcSEcCtD
Aminosalicylic Acid—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0103	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—amyotrophic lateral sclerosis	0.00088	0.427	CrCbGaD
Aminosalicylic Acid—Mesalazine—PTGS2—amyotrophic lateral sclerosis	0.000691	0.335	CrCbGaD
Aminosalicylic Acid—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000534	0.00241	CbGpPWpGaD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—amyotrophic lateral sclerosis	0.000522	0.00236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.000519	0.00235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—CASP9—amyotrophic lateral sclerosis	0.000519	0.00235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Osteopontin-mediated events—MMP9—amyotrophic lateral sclerosis	0.000519	0.00235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—CASP9—amyotrophic lateral sclerosis	0.000507	0.00229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—CASP9—amyotrophic lateral sclerosis	0.000503	0.00227	CbGpPWpGaD
Aminosalicylic Acid—CHUK—FAS (CD95) signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000498	0.00225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—ERBB4—amyotrophic lateral sclerosis	0.000493	0.00223	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—GSR—amyotrophic lateral sclerosis	0.000493	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—CASP9—amyotrophic lateral sclerosis	0.000491	0.00222	CbGpPWpGaD
Aminosalicylic Acid—Salicylic acid—PTGS2—amyotrophic lateral sclerosis	0.00049	0.238	CrCbGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—ATF1—amyotrophic lateral sclerosis	0.000486	0.0022	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	0.000486	0.0022	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00047	0.00213	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.000468	0.00212	CbGpPWpGaD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000468	0.00212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—ATF1—amyotrophic lateral sclerosis	0.000457	0.00207	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000456	0.00206	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000453	0.00205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—IGF1—amyotrophic lateral sclerosis	0.000451	0.00204	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000449	0.00203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—RTN4—amyotrophic lateral sclerosis	0.000445	0.00201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—ERBB4—amyotrophic lateral sclerosis	0.000444	0.00201	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000442	0.002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000439	0.00199	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000437	0.00197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—ERBB4—amyotrophic lateral sclerosis	0.000434	0.00196	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000432	0.00195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000431	0.00195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00043	0.00195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—ERBB4—amyotrophic lateral sclerosis	0.00043	0.00195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000427	0.00193	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000424	0.00192	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000424	0.00192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB4—amyotrophic lateral sclerosis	0.00042	0.0019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000418	0.00189	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.000408	0.00185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—ATF1—amyotrophic lateral sclerosis	0.000407	0.00184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—MMP9—amyotrophic lateral sclerosis	0.000407	0.00184	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000405	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000394	0.00178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—CASP9—amyotrophic lateral sclerosis	0.000388	0.00175	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000386	0.00174	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000382	0.00173	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000382	0.00173	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000379	0.00171	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000372	0.00168	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000371	0.00168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—CASP9—amyotrophic lateral sclerosis	0.000371	0.00168	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000369	0.00167	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000367	0.00166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.000365	0.00165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000359	0.00162	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000356	0.00161	CbGpPWpGaD
Aminosalicylic Acid—MPO—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.00035	0.00159	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000349	0.00158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—CASP9—amyotrophic lateral sclerosis	0.000349	0.00158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—CASP9—amyotrophic lateral sclerosis	0.000347	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—CASP9—amyotrophic lateral sclerosis	0.000345	0.00156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—CASP9—amyotrophic lateral sclerosis	0.000344	0.00155	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00034	0.00154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—CASP9—amyotrophic lateral sclerosis	0.000339	0.00153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—ERBB4—amyotrophic lateral sclerosis	0.000332	0.0015	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000325	0.00147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—CASP9—amyotrophic lateral sclerosis	0.000323	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—CASP9—amyotrophic lateral sclerosis	0.000323	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—CASP9—amyotrophic lateral sclerosis	0.000323	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000321	0.00145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—IGF1—amyotrophic lateral sclerosis	0.000321	0.00145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—IGF1—amyotrophic lateral sclerosis	0.000321	0.00145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—CASP9—amyotrophic lateral sclerosis	0.00032	0.00145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—ERBB4—amyotrophic lateral sclerosis	0.000318	0.00144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—CASP9—amyotrophic lateral sclerosis	0.000318	0.00144	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000316	0.00143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—CASP9—amyotrophic lateral sclerosis	0.000316	0.00143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000313	0.00141	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000305	0.00138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000304	0.00138	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000301	0.00136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—ATF1—amyotrophic lateral sclerosis	0.000301	0.00136	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000301	0.00136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.0003	0.00136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—CASP9—amyotrophic lateral sclerosis	0.000299	0.00135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—ERBB4—amyotrophic lateral sclerosis	0.000299	0.00135	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000297	0.00135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—ERBB4—amyotrophic lateral sclerosis	0.000297	0.00134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—ERBB4—amyotrophic lateral sclerosis	0.000296	0.00134	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000295	0.00134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—ERBB4—amyotrophic lateral sclerosis	0.000294	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—ERBB4—amyotrophic lateral sclerosis	0.00029	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—CASP3—amyotrophic lateral sclerosis	0.000289	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—CASP9—amyotrophic lateral sclerosis	0.000286	0.0013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—MMP9—amyotrophic lateral sclerosis	0.000283	0.00128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—ERBB4—amyotrophic lateral sclerosis	0.000277	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—ERBB4—amyotrophic lateral sclerosis	0.000277	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—ERBB4—amyotrophic lateral sclerosis	0.000277	0.00125	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000276	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—ERBB4—amyotrophic lateral sclerosis	0.000274	0.00124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—ERBB4—amyotrophic lateral sclerosis	0.000272	0.00123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—ERBB4—amyotrophic lateral sclerosis	0.000271	0.00122	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00027	0.00122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TPK1—amyotrophic lateral sclerosis	0.000265	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000256	0.00116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—ERBB4—amyotrophic lateral sclerosis	0.000256	0.00116	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000255	0.00116	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000253	0.00114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000251	0.00114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—SQSTM1—amyotrophic lateral sclerosis	0.000251	0.00113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000248	0.00112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000247	0.00112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.000247	0.00112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.000245	0.00111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000245	0.00111	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000236	0.00107	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000233	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.000231	0.00105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00023	0.00104	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000223	0.00101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000222	0.001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.00022	0.000997	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000218	0.000984	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000218	0.000984	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000216	0.000978	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—VTA1—amyotrophic lateral sclerosis	0.000212	0.000959	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.000211	0.000957	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000209	0.000947	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000204	0.000922	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000201	0.00091	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.0002	0.000904	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000193	0.000874	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000191	0.000866	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—amyotrophic lateral sclerosis	0.00019	0.000859	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000189	0.000856	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.000189	0.000853	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—TP53—amyotrophic lateral sclerosis	0.000186	0.000839	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00018	0.000815	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000176	0.000796	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000166	0.000753	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000166	0.000749	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000166	0.000749	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—APOE—amyotrophic lateral sclerosis	0.000164	0.000744	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000162	0.000732	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000161	0.000727	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000161	0.000727	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000159	0.000718	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000159	0.000717	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	0.000157	0.00071	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000155	0.0007	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000154	0.000699	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000154	0.000698	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000152	0.000687	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000152	0.000685	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PLB1—amyotrophic lateral sclerosis	0.000145	0.000657	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000145	0.000656	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000145	0.000655	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000141	0.000637	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000138	0.000624	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000132	0.000599	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000132	0.000597	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000132	0.000595	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000132	0.000595	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000131	0.000594	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—VCP—amyotrophic lateral sclerosis	0.000129	0.000586	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000128	0.00058	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000128	0.00058	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000126	0.000568	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	0.000126	0.000568	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000123	0.000555	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000121	0.000546	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00012	0.000544	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00012	0.000542	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000113	0.00051	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000112	0.000506	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000112	0.000505	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000109	0.000492	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000108	0.000486	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000105	0.000477	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000105	0.000476	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000103	0.000467	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000102	0.00046	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.92e-05	0.000449	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	9.91e-05	0.000449	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	9.86e-05	0.000446	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	9.71e-05	0.000439	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.56e-05	0.000433	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	9.51e-05	0.00043	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	9.51e-05	0.00043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CST3—amyotrophic lateral sclerosis	9.29e-05	0.00042	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	9.28e-05	0.00042	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.08e-05	0.000411	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.07e-05	0.00041	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—C3—amyotrophic lateral sclerosis	8.94e-05	0.000404	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.78e-05	0.000397	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	8.6e-05	0.000389	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—C3—amyotrophic lateral sclerosis	8.58e-05	0.000388	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.53e-05	0.000386	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	8.38e-05	0.000379	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—hindlimb—amyotrophic lateral sclerosis	8.22e-05	0.141	CbGeAlD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	8.22e-05	0.000372	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SQSTM1—amyotrophic lateral sclerosis	8.19e-05	0.000371	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.84e-05	0.000354	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.8e-05	0.000353	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.71e-05	0.000349	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ATF1—amyotrophic lateral sclerosis	7.68e-05	0.000348	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	7.67e-05	0.000347	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.63e-05	0.000345	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	7.59e-05	0.000343	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CASP9—amyotrophic lateral sclerosis	7.32e-05	0.000331	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	7.21e-05	0.000326	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	7.15e-05	0.000324	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—appendage—amyotrophic lateral sclerosis	7.05e-05	0.121	CbGeAlD
Aminosalicylic Acid—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.88e-05	0.000311	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CASP9—amyotrophic lateral sclerosis	6.76e-05	0.000306	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	6.65e-05	0.000301	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—amyotrophic lateral sclerosis	6.45e-05	0.000292	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	6.44e-05	0.000291	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.28e-05	0.000284	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB4—amyotrophic lateral sclerosis	6.26e-05	0.000283	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.06e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40LG—amyotrophic lateral sclerosis	5.89e-05	0.000266	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB4—amyotrophic lateral sclerosis	5.78e-05	0.000262	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	5.5e-05	0.000249	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	5.46e-05	0.000247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.3e-05	0.00024	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—C3—amyotrophic lateral sclerosis	5.2e-05	0.000235	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.98e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.97e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—cerebellum—amyotrophic lateral sclerosis	4.89e-05	0.0837	CbGeAlD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.87e-05	0.00022	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.73e-05	0.000214	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—amyotrophic lateral sclerosis	4.47e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.42e-05	0.0002	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.3e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.05e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	4e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—brain—amyotrophic lateral sclerosis	3.98e-05	0.068	CbGeAlD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.81e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.7e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	3.43e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.4e-05	0.000154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.36e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.13e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—amyotrophic lateral sclerosis	3.07e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—MPO—spinal cord—amyotrophic lateral sclerosis	2.94e-05	0.0503	CbGeAlD
Aminosalicylic Acid—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.94e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—nervous system—amyotrophic lateral sclerosis	2.93e-05	0.0501	CbGeAlD
Aminosalicylic Acid—ALOX5—central nervous system—amyotrophic lateral sclerosis	2.82e-05	0.0482	CbGeAlD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	2.8e-05	0.000126	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—cerebellum—amyotrophic lateral sclerosis	2.76e-05	0.0471	CbGeAlD
Aminosalicylic Acid—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.7e-05	0.000122	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	2.65e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.59e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—MPO—nervous system—amyotrophic lateral sclerosis	2.48e-05	0.0424	CbGeAlD
Aminosalicylic Acid—MPO—central nervous system—amyotrophic lateral sclerosis	2.39e-05	0.0408	CbGeAlD
Aminosalicylic Acid—PTGS2—embryo—amyotrophic lateral sclerosis	2.34e-05	0.04	CbGeAlD
Aminosalicylic Acid—ALOX5—brain—amyotrophic lateral sclerosis	2.24e-05	0.0383	CbGeAlD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	2.22e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.99e-05	9.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.92e-05	8.67e-05	CbGpPWpGaD
Aminosalicylic Acid—MPO—brain—amyotrophic lateral sclerosis	1.89e-05	0.0324	CbGeAlD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.88e-05	8.52e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.69e-05	7.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	1.5e-05	0.0256	CbGeAlD
Aminosalicylic Acid—PTGS1—spinal cord—amyotrophic lateral sclerosis	1.4e-05	0.0239	CbGeAlD
Aminosalicylic Acid—PTGS2—spinal cord—amyotrophic lateral sclerosis	1.33e-05	0.0228	CbGeAlD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.28e-05	5.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—nervous system—amyotrophic lateral sclerosis	1.18e-05	0.0201	CbGeAlD
Aminosalicylic Acid—PTGS1—central nervous system—amyotrophic lateral sclerosis	1.13e-05	0.0194	CbGeAlD
Aminosalicylic Acid—PTGS2—nervous system—amyotrophic lateral sclerosis	1.12e-05	0.0192	CbGeAlD
Aminosalicylic Acid—PTGS2—central nervous system—amyotrophic lateral sclerosis	1.08e-05	0.0185	CbGeAlD
Aminosalicylic Acid—PTGS2—cerebellum—amyotrophic lateral sclerosis	1.06e-05	0.0181	CbGeAlD
Aminosalicylic Acid—PTGS1—brain—amyotrophic lateral sclerosis	8.99e-06	0.0154	CbGeAlD
Aminosalicylic Acid—PTGS2—brain—amyotrophic lateral sclerosis	8.59e-06	0.0147	CbGeAlD
